News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Conference News AHA 2023 Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina Michael O'Riordan November 11, 2023
News Conference News AHA 2022 ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD Shelley Wood November 06, 2022
News Conference News AHA 2020 CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS Caitlin E. Cox November 20, 2020
News Conference News AHA 2020 When PCI Decisions Ignore FFR Results, Patients Pay a Price Caitlin E. Cox November 14, 2020
News Conference News AHA 2020 SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults Shelley Wood November 13, 2020
News Conference News AHA 2019 Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques Todd Neale November 21, 2019
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
Presentation AHA 2016 FUnctional Testing Underlying REvascularization: The FUTURE trial Presenter: Gilles Rioufol November 15, 2016
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016
News Conference News AHA 2016 Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis Michael O'Riordan November 13, 2016
News Conference News AHA 2015 Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain Shelley Wood November 08, 2015
News Conference News AHA 2014 FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes November 16, 2014